5-PARA-TOLYL-9,12-METHANO-8H-1,2,3,4,4A,8A,9,10,11,12,13,13A-DODECAHYDROPHTHALAZINO-[1,2-B]-QUINAZOLIN-8-ONE
Compound with spectra: 1 NMR
![5-PARA-TOLYL-9,12-METHANO-8H-1,2,3,4,4A,8A,9,10,11,12,13,13A-DODECAHYDROPHTHALAZINO-[1,2-B]-QUINAZOLIN-8-ONE](/api/compound/FsIKQ9H9yB.png?ph=true&h=300&w=458 "5-PARA-TOLYL-9,12-METHANO-8H-1,2,3,4,4A,8A,9,10,11,12,13,13A-DODECAHYDROPHTHALAZINO-[1,2-B]-QUINAZOLIN-8-ONE")
| SpectraBase Compound ID | FsIKQ9H9yB |
|---|---|
| InChI | InChI=1S/C23H27N3O/c1-13-6-8-14(9-7-13)20-17-4-2-3-5-18(17)22-24-21-16-11-10-15(12-16)19(21)23(27)26(22)25-20/h6-9,15-19,21H,2-5,10-12H2,1H3/t15-,16+,17+,18-,19+,21-/m1/s1 |
| InChIKey | SXFHMCQMDXTATH-REBNMZDTSA-N |
| Mol Weight | 361.49 g/mol |
| Molecular Formula | C23H27N3O |
| Exact Mass | 361.215413 g/mol |
| Enantiomer InChIKey | SXFHMCQMDXTATH-PLYBDPPMSA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
6,7-Ditert-butyl-4-phenyl-7-aza-1-phosphabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarbonitrile
10-Acetoxycaryachine
8-Ethoxycarbonyl-7H-9-(4-ethoxycarbonylphenylhydrazono)-pyrrolo[1,2-a]perimidin-10-one
CHOLESTEROL-SUCCINOBUCOL
(1Z)-7-Chloro-1-([(Z)-2-(diethylamino)propyl]imino)-10-hydroxy-3-[3-(trifluoromethyl)phenyl]-1,3,4,10-tetrahydro-9(2H)-acridinone
15.alpha.-Hydroxy-16.alpha.H-ent-atisan-14-one
15.beta.-Hydroxy-16.alpha.H-ent-atisan-14-one
Tricarbonyl[(1-4-.eta.)-5-exo-cyano-5-endo-(phenylthio)-1,3-cyclohexadiene]iron
Tricarbonyl[(1-4(.elata.)-5-(6-imino-4,5-dimethylcyclohexa-1,4-dien-3-only)-1,3-cyclohexadiene]iron
2,5-bis(3',4'-Dimethyl-5',6'-diphenyl-1'-phospha-nor-borna-2',5'-dien-2'-yl)thiophene
| Title | Journal or Book | Year |
|---|---|---|
| Saturated heterocycles.254. synthesis and stereochemistry of saturated or partially saturated pyridazino-[6,1-b]- and phthalazino[1,2-b]quinazolinones | Journal of Heterocyclic Chemistry | 1998 |